Suicide vaccines against animal herpesviruses: Bovine herpesvirus type 1 as a model

Informations projet

N° de convention de subvention: QLK5-CT-2000-51537

Date de début

Date de fin

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 0,00

Contribution de l’UE Aucune donnée

Coordonné par

Universite de Liege
Belgium

Objectif

Development of a novel strategy of vaccination against bovine herpesvirus 1 based on a suicide vaccine, which is able to perform only a single cycle of replication after intranasal inoculation. The vaccine combines the high immunogenic potential of a live vaccine and the safety of a killed vaccine.

Champ scientifique

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

Data not available

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

Universite de Liege

• Contribution de l’UE: Aucune donnée
• Adresse: Boulevard de Colonster, 20, B43b ; 4000 Liege ; Belgique
• Coût total: Aucune donnée

Participants (1)

Not available

Suède

• Contribution de l’UE: Aucune donnée
• Coût total: Aucune donnée